166 related articles for article (PubMed ID: 9617496)
1. Plasma and peritoneal endothelin levels and blood pressure in CAPD patients with or without erythropoietin replacement therapy.
Lebel M; Moreau V; Grose JH; Kingma I; Langlois S
Clin Nephrol; 1998 May; 49(5):313-8. PubMed ID: 9617496
[TBL] [Abstract][Full Text] [Related]
2. Peritoneal transport status influence on atherosclerosis/inflammation in CAPD patients.
Sezer S; Tutal E; Arat Z; Akçay A; Celik H; Ozdemir FN; Haberal M
J Ren Nutr; 2005 Oct; 15(4):427-34. PubMed ID: 16198934
[TBL] [Abstract][Full Text] [Related]
3. Nitric oxide is a marker of peritonitis in patients on continuous ambulatory peritoneal dialysis.
Choi KC; Jeong TK; Lee SC; Kim SW; Kim NH; Lee KY
Adv Perit Dial; 1998; 14():173-9. PubMed ID: 10649719
[TBL] [Abstract][Full Text] [Related]
4. Plasma endothelin levels and blood pressure in hemodialysis and in CAPD patients. Effect of subcutaneous erythropoietin replacement therapy.
Lebel M; Grose JH; Kingma I; Langlois S
Clin Exp Hypertens; 1994 Sep; 16(5):565-75. PubMed ID: 7951163
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of changes in serum and dialysate levels of cancer antigen 125 in stable continuous ambulatory peritoneal dialysis patients.
Passadakis P; Panagoutsos S; Thodis E; Tsivara I; Sopassi F; Kartali S; Vargemezis V
Adv Perit Dial; 1999; 15():40-4. PubMed ID: 10682070
[TBL] [Abstract][Full Text] [Related]
6. Use of bolus intraperitoneal iron dextran in continuous ambulatory peritoneal dialysis or continuous cyclic peritoneal dialysis patients receiving recombinant human erythropoietin.
Mars RL; Moles K; Pope K; Hargrove P
Adv Perit Dial; 1999; 15():60-4. PubMed ID: 10682073
[TBL] [Abstract][Full Text] [Related]
7. Recombinant human erythropoietin (rHuEPO) therapy has no effect on peritoneal transport in CAPD patients: a short-term study.
Wong PN; Mak SK; Lo KY; Tong GM; Wong AK
Adv Perit Dial; 1998; 14():11-3. PubMed ID: 10649682
[TBL] [Abstract][Full Text] [Related]
8. Parathyroid hormone contributes to variations in blood morphology in diabetic and non diabetic patients treated with continuous ambulatory peritoneal dialysis.
Grzegorzewska AE; Mariak I
Adv Perit Dial; 2001; 17():5-9. PubMed ID: 11510296
[TBL] [Abstract][Full Text] [Related]
9. [Evaluation of polyneuropathy severity in chronic renal failure patients on continuous ambulatory peritoneal dialysis or on maintenance hemodialysis].
Janda K; Stompór T; Gryz E; Szczudlik A; Drozdz M; Kraśniak A; Sułowicz W
Przegl Lek; 2007; 64(6):423-30. PubMed ID: 18159852
[TBL] [Abstract][Full Text] [Related]
10. [The effect of the number of peritonitis episodes on peritoneal membrane function].
Jovanović D; Nesić V; Dimitrijević Z
Srp Arh Celok Lek; 1999; 127(1-2):28-31. PubMed ID: 10377837
[TBL] [Abstract][Full Text] [Related]
11. Influence of dialysis duration, peritoneal transport parameters, and gender on effluent CA125 concentration in patients on peritoneal dialysis.
Mojahedi MJ; Hami M; Shakeri MT; Hekmat R
Iran J Kidney Dis; 2007 Oct; 1(2):78-81. PubMed ID: 19363281
[TBL] [Abstract][Full Text] [Related]
12. Peritoneal transport characteristics and dwelling time significantly impact ghrelin clearance in peritoneal dialysis patients.
Chang CC; Hung CH; Chen HL; Hwang KL; Lin CY
Nephrol Dial Transplant; 2007 Jan; 22(1):224-8. PubMed ID: 17005528
[TBL] [Abstract][Full Text] [Related]
13. [Plasma levels of atrial natriuretic peptide and its relationship with arterial blood pressure before and after peritoneal dialysate infusion].
Calzavara P; Da Rin G; Galardi N; Amici G; Vianello A; Mordacchini M; Maresca MC; Bocci C
Medicina (Firenze); 1990; 10(2):171-3. PubMed ID: 2148794
[TBL] [Abstract][Full Text] [Related]
14. Long-term follow-up of body size indices, residual renal function, and peritoneal transport characteristics in continuous ambulatory peritoneal dialysis.
Twardowski ZJ; Moore HL; Prowant BF; Satalowich R
Adv Perit Dial; 2009; 25():155-64. PubMed ID: 19886338
[TBL] [Abstract][Full Text] [Related]
15. Ambulatory blood pressure monitoring in haemodialysis and continuous ambulatory peritoneal dialysis (CAPD) patients.
Tonbul Z; Altintepe L; Sözlü C; Yeksan M; Yildiz A; Türk S
J Hum Hypertens; 2002 Aug; 16(8):585-9. PubMed ID: 12149665
[TBL] [Abstract][Full Text] [Related]
16. Residual renal function in children treated with continuous ambulatory peritoneal dialysis or automated peritoneal dialysis--a preliminary study.
Roszkowska-Blaim M; Skrzypczyk P; Drozdz D; Pietrzyk JA
Adv Perit Dial; 2009; 25():103-9. PubMed ID: 19886329
[TBL] [Abstract][Full Text] [Related]
17. Leptin in peritoneal dialysate from continuous ambulatory peritoneal dialysis patients.
Tsujimoto Y; Shoji T; Tabata T; Morita A; Emoto M; Nishizawa Y; Morii H
Am J Kidney Dis; 1999 Nov; 34(5):832-8. PubMed ID: 10561138
[TBL] [Abstract][Full Text] [Related]
18. Clearance of osteocalcin in adults with end-stage renal disease undergoing CAPD.
Klein JR; Grunewald RW; Steffgen J; Franz HE
Adv Perit Dial; 1991; 7():225-9. PubMed ID: 1680431
[TBL] [Abstract][Full Text] [Related]
19. Influence of blood volume on the blood pressure of predialysis and peritoneal dialysis patients treated with erythropoietin.
Anastassiades E; Howarth D; Howarth J; Shanks D; Waters H; Hyde K; Yin JL; Geary C; Gokal R
Nephrol Dial Transplant; 1993; 8(7):621-5. PubMed ID: 8396746
[TBL] [Abstract][Full Text] [Related]
20. Significance of brain natriuretic peptides in patients on continuous ambulatory peritoneal dialysis.
Nakatani T; Naganuma T; Masuda C; Uchida J; Sugimura T; Sugimura K
Int J Mol Med; 2002 Oct; 10(4):457-61. PubMed ID: 12239593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
